|
2024
|
Invention
|
Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis.
Aspects of the application provide... |
|
|
Invention
|
Methods of treatment using anti-c-met antibody drug conjugates. The present application pertains ... |
|
|
Invention
|
Composition and method for the diagnosis and treatment of iron-related disorders. Provided herein... |
|
|
Invention
|
Macrocyclic mcl-1 inhibitors and methods of use.
The present disclosure provides for compounds o... |
|
2023
|
Invention
|
N-methyl-4-(quinolin-2-yl)pyridin-2-amine compounds. The present disclosure provides compounds of... |
|
|
Invention
|
Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitor.
The invention re... |
|
|
Invention
|
Anti-garp-tgf-beta1/pd-1 combination therapy.
The present disclosure provides methods of treatin... |
|
|
Invention
|
Anti-garp-tgf-.beta.1/pd-1 combination therapy |
|
2022
|
Invention
|
Methods for treating anemia of kidney disease.
Aspects of the application provide hemojuvelin an... |
|
|
Invention
|
Methods for treating anemia of kidney disease. Aspects of the application provide hemojuvelin ant... |
|
|
Invention
|
Immunogenic products based on mutein amyloid beta (abeta) amino acid sequences and uses thereof. ... |
|
|
Invention
|
Dosing regimens for use in treating myelofibrosis and mpn-related disorders with navitoclax.
The... |
|
|
Invention
|
Methods of treating crohn's disease and ulcerative colitis.
The present disclosure relates to me... |
|
|
Invention
|
Methods of treating crohn's disease and ulcerative colitis. The present disclosure relates to met... |
|
2021
|
Invention
|
Spiro-cyclic amine derivatives as s1p modulators. The present invention is directed to spiro-cycl... |
|
|
Invention
|
Spiro-cyclic amine derivatives as s1p modulators.
The present invention is directed to spiro-cyc... |
|
|
Invention
|
Nanoencapsulation of antigen-binding molecules.
The present invention relates to nanospheres com... |
|
|
Invention
|
Nanoparticles based on optionally alkoxylated poly(alkyl cyanoacrylates) having a defined degree ... |
|
|
Invention
|
Anti-hemojuvelin (hjv) antibodies for treating anemia of chronic disease.
Aspects of the applica... |
|
|
Invention
|
Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis. Aspects of the application provide ... |
|
|
Invention
|
Anti-hemojuvelin (hjv) antibodies for treating anemia of chronic disease. Aspects of the applicat... |
|
|
Invention
|
Methods for treating spinal cord injury and pain.
Disclosed herein are anti-RGMa antibodies and ... |
|
|
Invention
|
Rgma fragment based diagnostic assay.
Provided are diagnostic assays and method s of using the d... |
|
|
Invention
|
Monoclonal antibodies against amyloid beta protein and uses thereof.
The subject invention relat... |
|
2020
|
Invention
|
Dosing regimens for use in treating myelofibrosis and mpn-related disorders with navitoclax. The ... |
|
|
Invention
|
Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulo... |
|
|
Invention
|
Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber l... |
|
|
Invention
|
Composition and method for the diagnosis and treatment of diseases associated with neurite degene... |
|
|
Invention
|
Antibodies against the rgm a protein and uses thereof.
The subject invention relates to isolated... |
|
|
Invention
|
Spiro-cyclic amine derivatives as s1p modulators. The present invention relates spiro-cyclic amin... |
|
2019
|
Invention
|
Tricyclic quinoline and quinoxaline derivatives.
The present invention relates to tricyclic quin... |
|
|
Invention
|
Stable aqueous anti-tau antibody formulations.
The present disclosure provides stable, aqueous, ... |
|
2018
|
Invention
|
1,2,3,4-substituted quinoline compounds as sip modulators.
The invention relates to 1,2,3,4-subs... |
|
2010
|
G/S
|
Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use... |
|
2008
|
G/S
|
Pharmaceutical and veterinary preparations. Printed matter, instructional and teaching material (... |
|
2006
|
G/S
|
Material treatment services namely processing and treatment of chemical substances for the develo... |
|
|
G/S
|
Material treatment services, namely processing and treatment of chemical substances for the devel... |
|
2005
|
G/S
|
Pharmaceutical, veterinary and sanitary preparations;
dietetic substances adapted for medical us... |
|
2004
|
G/S
|
Manures, adhesives; chemical products for the manufacture of manures, adhesive, paints, varnishes... |
|
2002
|
G/S
|
Processing of active agents and active agent/polymer mixtures for obtaining release profiles and ... |
|
2001
|
G/S
|
Physicochemical analysis, physicochemical characterisation and profiling, and morphological analy... |
|
|
G/S
|
Treatment of pharmaceutical active ingredients, vitamins, polymers and pharmaceutical excipients ... |
|
|
G/S
|
Manufacture of pharmaceutical products, namely pharmaceutical products with enhanced aqueous solu... |
|
1999
|
G/S
|
Préparations pour blanchir et autres substances pour
lessiver; savons, huiles essentielles, cosm... |
|
1996
|
G/S
|
[ chemicals for use in the manufacture of pharmaceuticals, cosmetics, food, animal feed, agricult... |
|
|
G/S
|
Produits chimiques destinés à l'industrie, la photographie,
l'agriculture, l'horticulture, la sy... |
|
1994
|
G/S
|
pharmaceutical products, namely cardiovascular drugs, drugs for the treatment of central nervous ... |
|
1993
|
G/S
|
pharmaceutical products; namely, cardiovascular drugs, [drugs for the treatment of central nervou... |
|
1985
|
G/S
|
Médicaments, sauf les antibiotiques et les allassotoniques
pharmacologiques et diététiques. |
